Status:
UNKNOWN
FIT FIRST FOR ALL - The Dose-Response Study
Lead Sponsor:
University of Southern Denmark
Collaborating Sponsors:
Novo Nordisk A/S
National Olympic Committee and Sports Confederation of Denmark
Conditions:
Primary Prevention
Eligibility:
All Genders
6-11 years
Phase:
NA
Brief Summary
In the present study, FIT FIRST 10 will run over 20 weeks, with cardiometabolic fitness as the primary outcome and project acceptability as the co-primary outcome. In this study the investigators will...
Detailed Description
Background Physical activity (PA) is an important part of a healthy lifestyle for children and youth, as it improves physical fitness, motor competences and well-being, and reduces the risk of develop...
Eligibility Criteria
Inclusion
- part of enrolled classes
Exclusion
- none
Key Trial Info
Start Date :
December 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 24 2024
Estimated Enrollment :
2400 Patients enrolled
Trial Details
Trial ID
NCT06180772
Start Date
December 10 2022
End Date
December 24 2024
Last Update
December 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Southern Denmark
Odense, Denmark, 5000